Cardioprotective Mechanisms of Sodium-Glucose Cotransporter-2 Inhibitors: What Have We Learned So Far?

By afschroeder • August 5, 2026

Qi L, Wright EM, Cai X. Cardioprotective Mechanisms of Sodium-Glucose Cotransporter-2 Inhibitors: What Have We Learned So Far? JACC Adv. 2026 Aug 4;5(9):103095. doi: 10.1016/j.jacadv.2026.103095. Epub ahead of print. PMID: 42551341.

Tags: Cardiology/Epi, cardioprotective effect, cardiovacular disease, heart failure, Post Doc, Publications, sodium-glucose cotransporter-2 inhibitor

Lung Function after Randomization to Metformin, Lifestyle Intervention or Placebo in the Diabetes Prevention Program Outcomes Study (DPPOS)

Pistenmaa CL, Doherty L, Hermann EA, Brown AL, Dabelea D, Holguin F, Watson K, Knowler WC, Temprosa M, Barr RG; DPP Research Group. Lung Function[...]

Novel Explantation Protocol for Cardiac Recovery and Device Weaning Post-Left Ventricular Assist Device Therapy: A Single-Center Experience

Kumar A, Mitchell AJ, Shahandeh N, Vucicevic D, Kwon MH, Srivastava PK, Nsair A, Kamath MY. Novel Explantation Protocol for Cardiac Recovery and Device Weaning[...]

Ventricular Arrhythmias After Self-Expanding Transcatheter Pulmonary Valve Replacement: A Report From the SERVE Registry

Armstrong AK, Goldstein BH, Aboulhosn J, Balzer D, Barry OM, Berman DP, Boe BA, Bocks ML, Cabalka AK, Fraint H, Kanter J, Keeshan B, Lamers[...]